Application | Comment | Organism |
---|---|---|
drug development | blocking the incorporation of the product galactofuranose into polysaccharides essential for pathogen viability or virulence may lead to novel therapeutics | Klebsiella pneumoniae |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2-[5-(3-bromo-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-yl]-3-phenyl-propionic acid | - |
Klebsiella pneumoniae | |
2-[[2-(4-bromo-phenyl)-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carbonyl]-amino]-benzoic acid | - |
Klebsiella pneumoniae | |
N-[4-oxo-5-(2-oxo-1,2-dihydro-indol-3-ylidene)-thiazolidin-2-ylidene]-benzenesulfonamide | - |
Klebsiella pneumoniae | |
uridine-5'-diphospho-(N-fluoresceinisothiocyano)hexanolamine | - |
Klebsiella pneumoniae |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
UDP-galactopyranose | Klebsiella pneumoniae | - |
UDP-galactofuranose | - |
r |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Klebsiella pneumoniae | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
UDP-galactopyranose | - |
Klebsiella pneumoniae | UDP-galactofuranose | - |
r |
Synonyms | Comment | Organism |
---|---|---|
UDP-galactopyranose mutase | - |
Klebsiella pneumoniae |
UGM | - |
Klebsiella pneumoniae |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0013 | - |
uridine-5'-diphospho-(N-fluoresceinisothiocyano)hexanolamine | - |
Klebsiella pneumoniae | |
0.0016 | - |
2-[5-(3-bromo-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-yl]-3-phenyl-propionic acid | - |
Klebsiella pneumoniae | |
0.0046 | - |
2-[[2-(4-bromo-phenyl)-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carbonyl]-amino]-benzoic acid | - |
Klebsiella pneumoniae | |
0.017 | - |
N-[4-oxo-5-(2-oxo-1,2-dihydro-indol-3-ylidene)-thiazolidin-2-ylidene]-benzenesulfonamide | - |
Klebsiella pneumoniae |